Credit Suisse’s Blueprint Medicines BPMC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$6.55M Buy
69,100
+729
+1% +$69.2K 0.01% 1148
2023
Q4
$6.31M Sell
68,371
-986
-1% -$90.9K 0.01% 1195
2023
Q3
$3.48M Sell
69,357
-6,122
-8% -$307K ﹤0.01% 1489
2023
Q2
$4.77M Buy
75,479
+12,203
+19% +$771K ﹤0.01% 1358
2023
Q1
$2.85M Buy
63,276
+3,726
+6% +$168K ﹤0.01% 1648
2022
Q4
$2.61M Buy
59,550
+1,110
+2% +$48.6K ﹤0.01% 1717
2022
Q3
$3.85M Buy
58,440
+2,819
+5% +$186K ﹤0.01% 1404
2022
Q2
$2.81M Sell
55,621
-2,261
-4% -$114K ﹤0.01% 1659
2022
Q1
$3.7M Buy
57,882
+5,363
+10% +$343K ﹤0.01% 1662
2021
Q4
$5.63M Sell
52,519
-923
-2% -$98.9K ﹤0.01% 1426
2021
Q3
$5.49M Buy
53,442
+4,452
+9% +$458K ﹤0.01% 1463
2021
Q2
$4.31M Sell
48,990
-2,730
-5% -$240K ﹤0.01% 1633
2021
Q1
$5.03M Sell
51,720
-30,968
-37% -$3.01M ﹤0.01% 1540
2020
Q4
$9.27M Buy
82,688
+21,886
+36% +$2.45M ﹤0.01% 1156
2020
Q3
$5.64M Sell
60,802
-17,327
-22% -$1.61M ﹤0.01% 1240
2020
Q2
$6.09M Buy
78,129
+36,665
+88% +$2.86M ﹤0.01% 1204
2020
Q1
$2.42M Sell
41,464
-98,308
-70% -$5.75M ﹤0.01% 1554
2019
Q4
$11.2M Buy
139,772
+101,758
+268% +$8.15M 0.01% 1011
2019
Q3
$2.79M Buy
38,014
+7,796
+26% +$573K ﹤0.01% 1717
2019
Q2
$2.85M Sell
30,218
-11,637
-28% -$1.1M ﹤0.01% 1698
2019
Q1
$3.35M Sell
41,855
-5,154
-11% -$413K ﹤0.01% 1586
2018
Q4
$2.53M Sell
47,009
-4,399
-9% -$237K ﹤0.01% 1661
2018
Q3
$4.01M Buy
51,408
+7,833
+18% +$611K ﹤0.01% 1515
2018
Q2
$2.77M Sell
43,575
-5,740
-12% -$364K ﹤0.01% 1835
2018
Q1
$4.52M Buy
49,315
+13,804
+39% +$1.27M ﹤0.01% 1487
2017
Q4
$2.68M Sell
35,511
-10,707
-23% -$807K ﹤0.01% 1830
2017
Q3
$3.22M Buy
46,218
+10,974
+31% +$765K ﹤0.01% 1773
2017
Q2
$1.79M Sell
35,244
-4,801
-12% -$243K ﹤0.01% 1968
2017
Q1
$1.6M Buy
40,045
+8,650
+28% +$346K ﹤0.01% 2188
2016
Q4
$880K Buy
31,395
+11,725
+60% +$329K ﹤0.01% 2773
2016
Q3
$584K Sell
19,670
-5,918
-23% -$176K ﹤0.01% 3019
2016
Q2
$519K Buy
+25,588
New +$519K ﹤0.01% 3104